ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 27 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6 | -71.4% | 2,496 | -59.1% | 0.00% | – |
| Q2 2023 | $21 | -95.5% | 6,096 | -84.1% | 0.00% | -100.0% |
| Q4 2022 | $462 | -99.8% | 38,427 | -11.1% | 0.00% | – |
| Q3 2022 | $280,000 | +201.1% | 43,218 | +112.2% | 0.00% | – |
| Q2 2022 | $93,000 | -5.1% | 20,363 | +193.8% | 0.00% | – |
| Q4 2021 | $98,000 | +58.1% | 6,930 | -71.3% | 0.00% | – |
| Q3 2020 | $62,000 | +100.0% | 24,124 | +295.2% | 0.00% | – |
| Q4 2019 | $31,000 | +416.7% | 6,104 | +243.9% | 0.00% | – |
| Q2 2019 | $6,000 | +100.0% | 1,775 | +71.5% | 0.00% | – |
| Q4 2018 | $3,000 | +50.0% | 1,035 | +89.2% | 0.00% | – |
| Q3 2018 | $2,000 | -89.5% | 547 | -79.5% | 0.00% | -100.0% |
| Q3 2016 | $19,000 | -44.1% | 2,673 | -35.9% | 0.00% | -50.0% |
| Q2 2016 | $34,000 | +580.0% | 4,173 | +454.9% | 0.00% | – |
| Q1 2016 | $5,000 | -81.5% | 752 | -76.3% | 0.00% | -100.0% |
| Q4 2015 | $27,000 | +2600.0% | 3,177 | +1715.4% | 0.00% | – |
| Q4 2014 | $1,000 | – | 175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 781,292 | $2,039,172 | 1.87% |
| GSA CAPITAL PARTNERS LLP | 88,923 | $232 | 0.02% |
| Glass Jacobson Investment Advisors llc | 12,255 | $31,986 | 0.02% |
| Rathbones Group PLC | 289,803 | $756,386 | 0.01% |
| N.E.W. Advisory Services LLC | 12,960 | $33,826 | 0.01% |
| Virtu Financial LLC | 17,388 | $45 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $14,687 | 0.00% |
| ALGERT GLOBAL LLC | 14,680 | $38 | 0.00% |
| Close Asset Management Ltd | 11,400 | $30 | 0.00% |
| Altshuler Shaham Ltd | 12,847 | $33,408 | 0.00% |